Trastuzumab deruxtecan is also called Enhertu®. It is a combination of a type of targeted therapy drug called a monoclonal antibodies and a chemotherapy drug called deruxtecan. Trastuzumab deruxtecan ...

If you or a loved one has cancer, our local Macmillan Cancer Support Centres are here for you. We take the time to get to know you face-to-face to find out what really matters to you and get you the ...

No matter how your professional role supports people living with cancer, we have up to date resources, tools and information to help you with your work. Get resources and tools to support you if you ...

Building on our success with the Recovery Package, we're committed to delivering personalised care for people living with cancer. Personalised Care and Support Planning (PCSP) helps people living with ...

Cervical cancer develops very slowly from abnormal cell changes in the cervix. These changes do not cause any symptoms, but they may be found with cervical screening tests. If the tests show abnormal ...

Skin cancers can be split into 2 groups: non-melanoma, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) melanoma, including melanoma, lentigo maligna melanoma, superficial ...

Sepsis may also be called blood poisoning. It is a serious and potentially life-threatening complication of an infection. Sepsis happens when the body reacts to an infection and attacks its own organs ...

CAR-T stands for chimeric antigen receptor T-cell. This therapy is a type of immunotherapy. It works by changing some of your body’s immune cells to make them better at fighting cancer cells. Another ...

Stereotactic radiosurgery (SRS) is a way of giving radiotherapy to a brain tumour. It is given as a single high dose of radiotherapy, to a small area. Sometimes it may be divided into smaller doses ...

Run 13.1 miles through the pristine, winding streets of historic Oxford. The route begins in the city centre and passes through Old Marston village, the River Cherwell, Oxford University’s impressive ...

In most cases, experts do not know what causes a primary brain tumour. Research is going on to find out more. In almost all cases, experts do not know what causes a primary brain tumour. There are ...

Leading oncologist and Macmillan Cancer Support’s Chief Medical Officer talks on the misleading cancer claims around anti-parasitic drug, ivermectin. I have been an oncologist long enough to see many ...